Effects of a combined treatment with tamoxifen and estrogen receptor β agonists on human breast cancer cell lines (original) (raw)
Non-genomic actions of estradiol and 4-OH-tamoxifen on murine breast cancer cells
Elisa Bal Kier Joffé
Oncology Reports, 2014
View PDFchevron_right
Estrogen Receptor β Expression Is Associated with Tamoxifen Response in ERα-Negative Breast Carcinoma
Lao Saal
Clinical Cancer Research, 2007
View PDFchevron_right
Estrogen Receptor Expression Is Associated with Tamoxifen Response in ER -Negative Breast Carcinoma
Patrik Edén
Clinical Cancer Research, 2007
View PDFchevron_right
Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines
Nelson Rangel
Breast Cancer: Targets and Therapy
View PDFchevron_right
Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines
Rosette Lidereau
Endocrine Related Cancer, 2005
View PDFchevron_right
Different estrogen receptor structural domains are required for estrogen- and tamoxifen-dependent anti-proliferative activity in human mammary epithelial cells expressing an exogenous estrogen receptor
D. Zajchowski
The Journal of Steroid Biochemistry and Molecular Biology, 1997
View PDFchevron_right
Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells
Oliver Treeck
Breast Cancer Research and Treatment, 2009
View PDFchevron_right
Estrogenic effect of tamoxifen and its derivatives on the proliferation of MCF7 human breast tumor cells
CARLOS SONNENSCHEIN
Life Sciences, 1985
View PDFchevron_right
MCF-7 breast cancer cells overexpressing transfectedc-erbB-2 have anin vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivityin vivo
Francis Kern
Breast Cancer Research and Treatment, 1995
View PDFchevron_right
Wild-type oestrogen receptor beta (ERβ1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers
Akram Mohamed
British Journal of Cancer, 2004
View PDFchevron_right
Characterization of New Estrogen Receptor Destabilizing Compounds: Effects on Estrogen-Sensitive and Tamoxifen-Resistant Breast Cancer
Karsten Parczyk
JNCI Journal of the National Cancer Institute, 2004
View PDFchevron_right
Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation
catherine nguyen
Journal of Molecular Endocrinology, 2004
View PDFchevron_right
Comparison of the effects of the antiestrogens EM-800 and tamoxifen on the growth of human breast ZR-75-1 cancer xenografts in nude mice
Bernard Candas
Cancer research, 1998
View PDFchevron_right
Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion
Marcel Garcia
Critical Reviews in Oncology/Hematology, 2004
View PDFchevron_right
Inducible upregulation of oestrogen receptor-β1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells
Jim Davie
Journal of Molecular Endocrinology, 2005
View PDFchevron_right
“Dwarf” Estrogen Receptor in Breast Cancer and Resistance to Tamoxifen
Craig Allred
Journal of Clinical Oncology, 2009
View PDFchevron_right
Estrogen receptor (ER) β1 and ERβcx/β2 inhibit ERα function differently in breast cancer cell line MCF7
英孝 江口
Oncogene, 2003
View PDFchevron_right
Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer
Gunnar Mellgren
BMC Cancer, 2012
View PDFchevron_right
Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen
Todd Skaar
Cancer Chemotherapy and Pharmacology, 2005
View PDFchevron_right
Effect of Low-Dose Tamoxifen on Steroid Receptor Coactivator 3/Amplified in Breast Cancer 1 in Normal and Malignant Human Breast Tissue
sara gandini
Clinical Cancer Research, 2010
View PDFchevron_right
Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen
David Zava
Cancer research, 1984
View PDFchevron_right
The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells
Bindu Malla
2011
View PDFchevron_right
Influence of cellular ERα/ERβ ratio on the ERα-agonist induced proliferation of human T47D breast cancer cells
Ana Sotoca Covaleda
2008
View PDFchevron_right
Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
M. Subramaniam, Vivian Negron
Breast Cancer Research, 2011
View PDFchevron_right
Mechanisms governing the accumulation of estrogen receptor alpha in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens
Guy Leclercq
The Journal of Steroid Biochemistry and Molecular Biology, 2003
View PDFchevron_right
Estrogen receptor- mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen
Kenneth T MacLeod
Endocrine Related Cancer, 2005
View PDFchevron_right
Tamoxifen non-estrogen receptor mediated molecular targets
Sergei Tjulandin
Oncology Reviews, 2012
View PDFchevron_right
Estrogen receptor mediated and cytotoxic effects of the antiestrogen tamoxifen and 4-hydroxytamoxifen
David Zava
Cancer Research
View PDFchevron_right
Inducible upregulation of oestrogen receptor- 1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells
James R Davie
Journal of Molecular Endocrinology, 2005
View PDFchevron_right
The expression and function of estrogen receptor ( and ( in human breast cancer and its clinical application
Keiji Tanimoto
Endocrine Related Cancer
View PDFchevron_right